SCHEMBL45864

SCHEMBL45864

C[C@H]1C[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12675735 1.00
SCHEMBL12085144 1.00
SCHEMBL12473717 1.00
SCHEMBL12675725 1.00
SCHEMBL46095 1.00
SCHEMBL684418 1.00
SCHEMBL5586361 1.00
SCHEMBL5586362 1.00
Ammonia Solution, Strong SCHEMBL27563464 0.95
Ammonia Solution, Strong SCHEMBL28088729 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170057928-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GILEAD SCIENCES, INC. 2017-03-02 US disclosed
US-9302120-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-04-05 US disclosed
US-9079913-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2015-07-14 US disclosed
US-20140378680-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2014-12-25 US disclosed
US-8877796-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-11-04 US disclosed
US-20140148494-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-05-29 US disclosed
US-8680132-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-03-25 US disclosed
US-8629141-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-01-14 US disclosed
US-20130296303-A1 SPIRO-OXINDOLE MDM2 ANTAGONISTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-11-07 US disclosed
US-8518984-B2 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2013-08-27 US disclosed
US-8486950-B2 Janus kinase inhibitor compounds and methods F. HOFFMANN-LA ROCHE AG (CH) 2013-07-16 US disclosed
US-20120078377-A1 SYSTEMS, DEVICES AND METHODS FOR PROVIDING THERAPY TO AN ANATOMICAL STRUCTURE USING HIGH FREQUENCY PRESSURE WAVES AND/OR CRYOGENIC TEMPERATURES ENTRIGUE SURGICAL, INC. (US) 2012-03-29 US disclosed
US-20110201694-A1 Compositions and Methods for Treatment of Disorders of Protein Aggregation MCLAURIN JOANNE 2011-08-18 US disclosed
WO-2011060049-A2 SPIRO-OXINDOLE MDM2 ANTAGONISTS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-05-19 WO disclosed
US-20110022172-A1 Disposable Medical Device for Engaging with Reusable Medical Instrument and Methods of Use ENTRIGUE SURGICAL, INC. (US) 2011-01-27 US disclosed
US-20110015734-A1 Methods for Providing Therapy to an Anatomical Structure ENTRIGUE SURGICAL, INC. (US) 2011-01-20 US disclosed
US-20110015667-A1 Systems, Devices and Methods for Providing Therapy to an Anatomical Structure ENTRIGUE SURGICAL, INC. (US) 2011-01-20 US disclosed
US-20100312338-A1 SYSTEMS, DEVICES AND METHODS FOR PROVIDING THERAPY TO AN ANATOMICAL STRUCTURE ENTRIGUE SURGICAL, INC. (US) 2010-12-09 US disclosed